Loading...
XNYS
DGX
Market cap25bUSD
Oct 08, Last price  
230.81USD
1D
1.65%
1Q
11.27%
Jan 2017
151.15%
Name

Quest Diagnostics Inc

Chart & performance

D1W1MN
XNYS:DGX chart
P/E
25.68
P/S
2.31
EPS
8.99
Div yield, %
1.36%
Shrs. gr., 5y
-3.64%
Rev. gr., 5y
3.18%
Revenues
11.04b
+11.78%
6,268,659,0006,704,907,0007,249,400,0007,455,200,0007,368,900,0007,510,500,0007,382,600,0007,146,000,0007,435,000,0007,493,000,0007,515,000,0007,709,000,0007,531,000,0007,726,000,0009,437,000,00010,788,000,0009,883,000,0009,252,000,0009,872,000,00011,035,000,000
Net income
992m
+13.89%
586,421,000339,939,000581,500,000729,100,000720,900,000470,600,000555,700,000849,000,000556,000,000709,000,000645,000,000772,000,000736,000,000858,000,0001,431,000,0001,995,000,000946,000,000854,000,000871,000,000992,000,000
CFO
1.89b
+41.38%
951,896,000926,924,0001,063,100,000997,400,0001,118,000,000895,500,0001,187,100,000652,000,000938,000,000810,000,0001,069,000,0001,175,000,0001,200,000,0001,243,000,0002,005,000,0002,233,000,0001,718,000,0001,272,000,0001,334,000,0001,886,000,000
Dividend
Oct 06, 20260.86 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

As an energy infrastructure firm, Digi Power X Inc. is dedicated to fostering the growth of energy assets across the United States through the development of specialized data centers. Its operations are diversified across three primary business lines: cryptocurrency mining, energy sales, and colocation services. Beyond these core segments, the company actively engages in cryptocurrency mining, offers power supply and space leasing to clients, and sells electrical power. Its clientele includes industrial entities and participants in energy markets. Headquartered in Miami, Florida, the firm rebranded from Digihost Technology Inc. to Digi Power X Inc. in March 2025.

Related entities

Subsidiaries (4)
Blueprint Genetics Oy
QUEST DIAGNOSTICS HTAS INDIA PRIVATE LIMITED
QUEST DIAGNOSTICS INDIA PRIVATE LIMITED
QUEST DIAGNOSTICS CLINICAL LABORATORIES, INC.

Key people

James Davis
Chairman of the Board, President, Chief Executive Officer · since 2023
Catherine Doherty
Executive Vice President - Regional Businesses · since 2024
Chief Financial Officer, Executive Vice President · since 2022
Adrienne Brott
Senior Vice President, Chief Quality and Regulatory Affairs Officer · since 2024
Mark Delaney
Senior Vice President, Chief Commercial Officer · since 2022
Karthik Kuppusamy
Senior Vice President - Clinical Solutions · since 2022
Patrick Plewman
Senior Vice President - Diagnostic Services · since 2022
Michael Prevoznik
Senior Vice President, General Counsel · since 2003
Robert Carter
Independent Director · since 2024
Independent Director · since 2023
Tracey Doi
Independent Director · since 2021
Independent Director · since 2014
Wright Lassiter
Independent Director · since 2020
Independent Director · since 2014
Independent Director · since 2019
Gary Pfeiffer
Independent Director · since 2004
Lead Independent Director · since 2021
IPO date
Dec 17, 1996
Employees
40,000
Domiciled in
US
Incorporated in
US
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
500 PLAZA DRIVE
SECAUCUS, NJ 07094
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT